EUVIMEDOdkrijte EUVIMED
Open access

A novel acquired resistance mechanism to 5‐aminolevulinic acid‐mediated photodynamic therapy with ABCG2 inhibition

Sharayu Chandratre, Jordyn Olsen, Bin Chen iD

Photochemistry and Photobiology · 2025

DOI: 10.1111/php.14077 ↗

At a glance

Journal article in Photochemistry and Photobiology, 2025. Written by Sharayu Chandratre and 2 co-authors. Institution: Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, Saint Joseph's University, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: ATP Binding Cassette Transporter, Subfamily G, Member 2, Photochemotherapy, Aminolevulinic Acid, Drug Resistance, Neoplasm. 47 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, NIBIB NIH HHS, NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

We report the occurrence of acquired tumor cell resistance to 5‐aminolevulinic acid (ALA)‐mediated photodynamic therapy (PDT) in combination with ABCG2 inhibition. ALA‐PDT in combination with either an ABCG2 tool inhibitor Ko143 or a repurposed clinically‐relevant ABCG2 inhibitor lapatinib was highly effective in eradicating the H4 human glioma cells, resulting in minimal cell survival after treatment. However, after seven rounds of repeated treatments with light dose escalation, the resultant tumor cells became resistant to the combination therapy. The resistant sublines and the parental cell line showed similar ABCG2 activities and protein levels, indicating that it was not ABCG2 that caused the resistance. They also exhibited similar responses to PpIX‐PDT and mTOR inhibitor AZD2014, suggesting that alterations in PDT sensitivity and mTOR pathway had little contribution to the development of resistance phenotype. By determining the intracellular and extracellular PpIX levels, the activities and protein levels of heme biosynthesis enzymes, we found that porphobilinogen deaminase (PBGD) activity and protein level were significantly reduced in the resistant sublines, causing resistance to PDT by substantially reducing PpIX biosynthesis. A novel acquired resistance mechanism to ALA‐PDT with ABCG2 inhibition has been uncovered.

Subjects

MeSH terms (MEDLINE)

ATP Binding Cassette Transporter, Subfamily G, Member 2PhotochemotherapyAminolevulinic AcidDrug Resistance, NeoplasmPhotosensitizing AgentsNeoplasm ProteinsHumansCell Line, TumorProtoporphyrinsHeterocyclic Compounds, 4 or More RingsDiketopiperazines

Author keywords

5‐aminolevulinic acid (ALA)ABCG2heme biosynthesis pathwayhydroxymethylbilane synthase (HMBS)photodynamic therapy (PDT)porphobilinogen deaminase (PBGD)protoporphyrin IX (PpIX)

Substances

ATP Binding Cassette Transporter, Subfamily G, Member 2Aminolevulinic AcidABCG2 protein, humanPhotosensitizing AgentsNeoplasm Proteins3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid…Protoporphyrinsprotoporphyrin IXHeterocyclic Compounds, 4 or More RingsDiketopiperazines

Authors and institutions

  • Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, Saint Joseph's University, Philadelphia, Pennsylvania, USA.
  • Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID profiles: Bin Chen

Funding

  • NCI NIH HHS
  • NIBIB NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Chandratre, S., Olsen, J., & Chen, B. (2025). A novel acquired resistance mechanism to 5‐aminolevulinic acid‐mediated photodynamic therapy with ABCG2 inhibition. Photochemistry and Photobiology. https://doi.org/10.1111/php.14077

Vancouver

Chandratre S, Olsen J, Chen B. A novel acquired resistance mechanism to 5‐aminolevulinic acid‐mediated photodynamic therapy with ABCG2 inhibition. Photochemistry and Photobiology. 2025. doi:10.1111/php.14077

BibTeX
@article{Chandratre2025,
  author = {Chandratre, Sharayu and Olsen, Jordyn and Chen, Bin},
  title = {A novel acquired resistance mechanism to 5‐aminolevulinic acid‐mediated photodynamic therapy with ABCG2 inhibition},
  journal = {Photochemistry and Photobiology},
  year = {2025},
  doi = {10.1111/php.14077}
}
Start for free →